OpenBilldrug price receipt

NADAC week of 2026-10-14

GABAPENTIN 250 MG/5 ML SOLN

For 1 mL

Pharmacies pay

$0.09 – $0.17 filed

1 × $0.08761 to $0.1712 per ML (the 8 NDCs differ)

CMS NADAC · nadac-national-average-drug-acquisition-cost-20261014.csv · eff. 2026-02-18, 2026-09-23 · as of 2026-10-14 · retrieved 2026-10-17

Medicare

We don’t know yet

No Medicare reference price. Part D: OpenBill did not match this NDC to a usable Medicare Part D spending row. Either Part D has none for it, or the rows that share its name could not safely be tied to it (for example, they mix units, routes or release forms, or the drug is sold over the counter, which Part D does not cover). Part B: This NDC is not in the current quarter’s Medicare Part B NDC-HCPCS crosswalk, so it has no Part B payment limit.


The spread

We don’t know yet

There is no Medicare figure to compare with, so there is no spread.

Cost-plus estimate

$5.10 – $5.20 estimated

NADAC for the pack + 15% + $5.00 fee per fill

This is a model, not a price any pharmacy quoted. Shipping is not included. For a pack this cheap, the $5.00 fee is most of the estimate. How it is worked out

OpenBill calculation · nadac-national-average-drug-acquisition-cost-20261014.csv · NADAC eff. 2026-02-18, 2026-09-23 (file of 2026-10-14, retrieved 2026-10-17)

Open the interactive card Change the quantity, type what you were charged, and see every record in full.

What it is

GABAPENTIN 250 MG/5 ML SOLN is how the CMS NADAC file names this product. The FDA NDC Directory lists it as gabapentin.

FDA gives its dosage form as “solution” and “suspension” and its route as oral.

FDA lists 8 labelers (the companies named on the label) for its NDCs, among them PAI Holdings, LLC dba PAI Pharma, Camber Pharmaceuticals, Inc. and Acella Pharmaceuticals, LLC.

FDA lists no Established Pharmacologic Class for it.

The NADAC file of 2026-10-14 prices it under 8 NDCs (National Drug Codes).

NADAC classes it as a generic drug (rate-setting class G), and does not mark it as sold over the counter.

What pharmacies pay

Pharmacies pay $0.09 – $0.17 for 1 mL, depending on the NDC ($0.08761 to $0.1712 per ML), by the CMS NADAC file of 2026-10-14; those prices took effect between 2026-02-18 and 2026-09-23. That is what pharmacies pay their suppliers, not what they charge you.

NADAC’s explanation codes for it: 1, calculated from the most recently completed pharmacy survey; 4, carried forward from the previous file; 5, calculated based on package size; 6, the CMS Covered Outpatient Drug Product File S/I/N drug category was not applied when grouping drugs for the calculation.

The NADAC of 1 of these 8 NDCs was carried forward from an earlier file (NADAC explanation code 2 or 4), not newly surveyed: it took effect on 2026-02-18. The file is new; the price is not.

The 8 labelers

LabelerNDCsPharmacies pay per unit
Acella Pharmaceuticals, LLC1$0.08761 per ML filed
Advagen Pharma Ltd1$0.08761 per ML filed
Ajenat Pharmaceuticals LLC1$0.08761 per ML filed
Amneal Pharmaceuticals LLC1$0.1712 per ML filed
BioComp Pharma, Inc.1$0.08761 per ML filed
Camber Pharmaceuticals, Inc.1$0.08761 per ML filed
Mylan Pharmaceuticals Inc.1$0.08761 per ML filed
PAI Holdings, LLC dba PAI Pharma1$0.08761 per ML filed

When these prices took effect

All 8 NDCs, with labeler and price
  • 00121-1067-16 · PAI Holdings, LLC dba PAI Pharma · $0.08761 per ML · eff. 2026-09-23 filed
  • 31722-0069-47 · Camber Pharmaceuticals, Inc. · $0.08761 per ML · eff. 2026-09-23 filed
  • 42192-0608-16 · Acella Pharmaceuticals, LLC · $0.08761 per ML · eff. 2026-09-23 filed
  • 44523-0120-16 · BioComp Pharma, Inc. · $0.08761 per ML · eff. 2026-09-23 filed
  • 59762-5050-07 · Mylan Pharmaceuticals Inc. · $0.08761 per ML · eff. 2026-09-23 filed
  • 65162-0698-90 · Amneal Pharmaceuticals LLC · $0.1712 per ML · eff. 2026-02-18 filed carried forward
  • 72888-0104-25 · Advagen Pharma Ltd · $0.08761 per ML · eff. 2026-09-23 filed
  • 82983-0423-47 · Ajenat Pharmaceuticals LLC · $0.08761 per ML · eff. 2026-09-23 filed

Other strengths, forms and brands

20 other products in the NADAC file share the FDA nonproprietary name gabapentin with GABAPENTIN 250 MG/5 ML SOLN.

ProductPharmacies pay per unitMedicare per unit
GABAPENTIN 100 MG CAPSULE
generic · capsule
$0.02184 per EA filed
eff. 2026-09-23
$0.1192 per EA filed
Part D 2024 average
GABAPENTIN 250 MG/5 ML SOLN this page
generic · solution / suspension
$0.08761 to $0.1712 per ML filed
eff. 2026-02-18 to 2026-09-23
We don’t know yet
GABAPENTIN 300 MG CAPSULE
generic · capsule
$0.03142 per EA filed
eff. 2026-09-23
$0.1192 per EA filed
Part D 2024 average
GABAPENTIN 400 MG CAPSULE
generic · capsule
$0.04222 per EA filed
eff. 2026-09-23
$0.1192 per EA filed
Part D 2024 average
GABAPENTIN 600 MG TABLET
generic · tablet, film coated / tablet / tablet, coated
$0.06398 per EA filed
eff. 2026-09-23
$0.1192 per EA filed
Part D 2024 average
GABAPENTIN 800 MG TABLET
generic · tablet, film coated / tablet / tablet, coated
$0.08829 per EA filed
eff. 2026-09-23
$0.1192 per EA filed
Part D 2024 average
GABAPENTIN ER 300 MG TABLET
generic · tablet, film coated / tablet
$0.63846 per EA filed
eff. 2026-09-23
$5.0138 per EA filed
Part D 2024 average
GABAPENTIN ER 600 MG TABLET
generic · tablet, film coated / tablet
$1.02497 per EA filed
eff. 2026-09-23
$5.0138 per EA filed
Part D 2024 average
GABARONE 100 MG TABLET
brand · tablet
$8.78889 per EA filed
eff. 2026-09-23
We don’t know yet
GABARONE 400 MG TABLET
brand · tablet
$8.57111 per EA filed
eff. 2026-09-23
We don’t know yet
GRALISE ER 300 MG TABLET
brand · tablet, film coated
$10.18511 per EA filed
eff. 2026-09-23
We don’t know yet
GRALISE ER 450 MG TABLET
brand · tablet, film coated
$10.14274 per EA filed
eff. 2025-12-17
We don’t know yet
GRALISE ER 600 MG TABLET
brand · tablet, film coated
$10.15306 per EA filed
eff. 2026-09-23
We don’t know yet
GRALISE ER 900 MG TABLET
brand · tablet, film coated
$15.20748 per EA filed
eff. 2026-09-23
We don’t know yet
NEURONTIN 100 MG CAPSULE
brand · capsule
$2.95761 per EA filed
eff. 2026-01-01
$8.87549 per EA filed
Part D 2024 average
NEURONTIN 300 MG CAPSULE
brand · capsule
$7.37105 per EA filed
eff. 2026-09-23
$8.87549 per EA filed
Part D 2024 average
NEURONTIN 400 MG CAPSULE
brand · capsule
$8.86718 per EA filed
eff. 2026-01-01
$8.87549 per EA filed
Part D 2024 average
NEURONTIN 600 MG TABLET
brand · tablet, film coated
$14.11861 per EA filed
eff. 2026-09-23
$8.87549 per EA filed
Part D 2024 average
NEURONTIN 800 MG TABLET
brand · tablet, film coated
$16.88137 per EA filed
eff. 2026-09-23
$8.87549 per EA filed
Part D 2024 average
RELGAABI 300 MG CAPSULE
generic · capsule
$0.03142 per EA filed
eff. 2026-09-23
$0.1192 per EA filed
Part D 2024 average
RELGAABI 400 MG CAPSULE
generic · capsule
$0.04222 per EA filed
eff. 2026-09-23
$0.1192 per EA filed
Part D 2024 average

Part D is one average per brand and generic name, over every strength and form.

CMS NADAC · nadac-national-average-drug-acquisition-cost-20261014.csv · eff. between 2025-12-17 and 2026-09-23 (4 dates) · as of 2026-10-14 · retrieved 2026-10-17

Medicare Part D · DSD_PTD_RY26_P04_V10_DY24_BGM.csv · eff. 2024-01-01 to 2024-12-31 · as of 2026-06-25 · retrieved 2026-10-18

What Medicare paid

We don’t know yet; the card above says why.

What to ask at the counter

None of these figures is your price: what you pay depends on your pharmacy, your insurance, coupons and discounts.

Questions

Why does this page start at 1 mL?
The FDA package descriptions of this product’s NDCs give different amounts (470 mL, 473 mL). So the card starts at 1 ML; change it to match your prescription.